Promising lung cancer blood test delivers impressively accurate results

A new study led by researchers at Johns Hopkins Kimmel Cancer Center is showing a novel blood test can detect the presence of lung cancer with over 90 percent accuracy. The test uses artificial intelligence to identify abnormal patterns in fragments of… Continue reading Promising lung cancer blood test delivers impressively accurate results

Existing drug shows promise targeting common cancer mutation

Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now, researchers have identified an existing drug that could be repurposed to fight pancreatic cancer by targeting a key gene mut… Continue reading Existing drug shows promise targeting common cancer mutation

Existing drug shows promise targeting common cancer mutation

Difficult to detect and with a low survival rate, pancreatic cancer is one of the most insidious forms of the disease. But now, researchers have identified an existing drug that could be repurposed to fight pancreatic cancer by targeting a key gene mut… Continue reading Existing drug shows promise targeting common cancer mutation

“ImmunoBait” particles surf blood cells to fight metastatic lung tumors

Cancer has an unfortunate and often deadly tendency to spread through the body, and the most common location for secondary tumors to appear is the lungs. Now, scientists at Harvard’s Wyss Institute have developed a way to treat metastatic tumors in the… Continue reading “ImmunoBait” particles surf blood cells to fight metastatic lung tumors

MIT’s urine test for lung cancer could cut out unnecessary biopsies

Early detection is key when it comes boosting survival rates for cancer patients, and there are a lot of ways scientists are working to swing the odds in their favor. Urine tests that pick up biomarkers of the disease are one exciting possibility, and … Continue reading MIT’s urine test for lung cancer could cut out unnecessary biopsies